Then the plan will be to broaden the label of B-OM

Quote:

---

Then the plan will be to broaden the label of B-OM to cover all Chemo Radiation patients including HSTC - the numbers become unthinkable --- in the US Alone ---- 650,000 people annually in the U.S alone! World Wide?????? Hundreds of Millions. All will have the ability to be prescribed B-OM for prevention.

---

Woah! I missed something. 650K in the USA and 100M+ worldwide? I would think the USA is more than 0.65% of the chemo/radiation market. Where did you come up with such a large number for outside the USA? I ask because your stuff is usually bullet proof but at $200/patient you just made this a $20B/year drug with your figure.

Go IPIX!

All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.